MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1 | Zendy

Chengliang Yang | Zendy; Xiaoli Zheng | Zendy; Ke Ye | Zendy; Hong Ge | Zendy; Yanan Sun | Zendy; Yufei Lu | Zendy; Qingxia Fan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1

Author(s) -

Chengliang Yang,

Xiaoli Zheng,

Ke Ye,

Hong Ge,

Yanan Sun,

Yufei Lu,

Qingxia Fan

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000488412

Subject(s) - vimentin , microrna , biology , flow cytometry , cancer research , apoptosis , proliferating cell nuclear antigen , cell growth , epithelial–mesenchymal transition , transfection , immunohistochemistry , western blot , microbiology and biotechnology , cancer , cell culture , metastasis , immunology , gene , biochemistry , genetics

MicroRNAs (miRs) often contribute to the progression of non-small cell lung cancer (NSCLC) via regulation of mRNAs that are involved in lung homeostasis. We conducted a study aimed at exploring the roles of miR-183 in the proliferation, epithelial-mesenchymal transition (EMT), invasion and migration of human NSCLC cells via targeting MTA1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research